{"id":350634,"date":"2025-08-25T19:53:39","date_gmt":"2025-08-25T19:53:39","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-argenx-se\/"},"modified":"2025-08-25T19:53:39","modified_gmt":"2025-08-25T19:53:39","slug":"how-to-buy-argenx-se","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/","title":{"rendered":"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334108,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-350634","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"argenx SE (ARGX) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i biyoteknoloji \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse performans\u0131n\u0131, riskleri ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"argenx SE (ARGX) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu yenilik\u00e7i biyoteknoloji \u015firketine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel hisse performans\u0131n\u0131, riskleri ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Otoimm\u00fcn hastal\u0131k tedavisinde devrim yaratan bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? argenx SE (ARGX), \u015fu anda biyoteknoloji sekt\u00f6r\u00fcndeki en heyecan verici f\u0131rsatlardan birini temsil ediyor. \u00c7\u0131\u011f\u0131r a\u00e7an tedaviler ve patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesi ile bu Hollandal\u0131 imm\u00fcnoloji \u015firketi Wall Street'in dikkatini \u00e7ekti. ARGX'in neden bir sonraki ak\u0131ll\u0131 yat\u0131r\u0131m hamleniz olabilece\u011fini ve bunu tam olarak nas\u0131l ger\u00e7ekle\u015ftirece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Otoimm\u00fcn hastal\u0131k tedavisinde devrim yaratan bir \u015firkete yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? argenx SE (ARGX), \u015fu anda biyoteknoloji sekt\u00f6r\u00fcndeki en heyecan verici f\u0131rsatlardan birini temsil ediyor. \u00c7\u0131\u011f\u0131r a\u00e7an tedaviler ve patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesi ile bu Hollandal\u0131 imm\u00fcnoloji \u015firketi Wall Street'in dikkatini \u00e7ekti. ARGX'in neden bir sonraki ak\u0131ll\u0131 yat\u0131r\u0131m hamleniz olabilece\u011fini ve bunu tam olarak nas\u0131l ger\u00e7ekle\u015ftirece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 argenx Hisse Performans\u0131: G\u00fcncel Durum ve Kritik Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla argenx SE (ARGX) hisseleri <strong>580,00 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Ancak yat\u0131r\u0131m zamanlaman\u0131z i\u00e7in as\u0131l \u00f6nemli olan \u015fudur...<\/p> <p><strong>Takviminize Not Edin: 30 Ekim 2025<\/strong><\/p> <p>Bu tarih ARGX yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in her \u015feyi dramatik \u015fekilde de\u011fi\u015ftirebilir. \u015eirketin 2025 3. \u00c7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn ve tarihsel olarak bu t\u00fcr olaylar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiliyor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 ARGX Hisselerini Nas\u0131l Etkiler?<\/h3> <p>Son \u00e7eyreklerden \u00f6rnek desenleri g\u00f6stereyim:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>31 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>550 $ (tahmin)<\/td><td><strong>%5,5 Art\u0131\u015f<\/strong> (beklentileri a\u015ft\u0131)<\/td><\/tr> <tr><td>8 May\u0131s 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>520 $ (tahmin)<\/td><td><strong>%4,2 Art\u0131\u015f<\/strong> (sa\u011flam performans)<\/td><\/tr> <tr><td>\u015eubat 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>490 $ (tahmin)<\/td><td><strong>%8,0 Art\u0131\u015f<\/strong> (ola\u011fan\u00fcst\u00fc b\u00fcy\u00fcme)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend Bilgisi<\/strong>: argenx kazan\u00e7 tahminlerini tutarl\u0131 \u015fekilde a\u015ft\u0131\u011f\u0131nda\u2014ki bunu s\u00fcrekli yap\u0131yor\u2014hisse genellikle birka\u00e7 g\u00fcn i\u00e7inde %4-8 aras\u0131nda s\u0131\u00e7rama yap\u0131yor. 31 Temmuz raporu \u00f6zellikle etkileyiciydi; hisse ba\u015f\u0131na 3,74 $ kazan\u00e7, 2,84 $ olan konsens\u00fcs tahminini ezdi ge\u00e7ti.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ola\u011fan\u00fcst\u00fc ARGX Hikayesi<\/h2> <p>Mart'tan A\u011fustos 2025'e kadar ARGX hisseleri etkileyici bir <strong>%17,3<\/strong> de\u011fer art\u0131\u015f\u0131 sa\u011flad\u0131:<\/p> <ul> <li><strong>Mart 2025<\/strong>: 495 $ (k\u0131\u015f konsolidasyon sonras\u0131)<\/li> <li><strong>May\u0131s 2025<\/strong>: 535 $ (1. \u00e7eyrek kazan\u00e7 art\u0131\u015f\u0131 + \u00fcr\u00fcn hatt\u0131 ilerlemesi)<\/li> <li><strong>Temmuz 2025<\/strong>: 575 $ (2. \u00e7eyrek m\u00fcthi\u015f sonu\u00e7lar + FDA d\u00f6n\u00fcm noktalar\u0131)<\/li> <li><strong>A\u011fustos 2025<\/strong>: 580 $ (hafif geri \u00e7ekilme ile mevcut seviyeler)<\/li> <\/ul> <p><strong>S\u00fcrekli b\u00fcy\u00fcmenin nedeni nedir?<\/strong> \u00dc\u00e7 g\u00fc\u00e7l\u00fc fakt\u00f6r:<\/p> <ol> <li><strong>Gelir patlamas\u0131<\/strong>: 949 milyon $ 2. \u00e7eyrek k\u00fcresel sat\u0131\u015flar (<a href=\"https:\/\/argenx.com\/news\/2024\/argenx-reports-half-year-2025-financial-results-and-provides-sec\">2025 \u0130lk Yar\u0131 Raporu<\/a>)<\/li> <li><strong>Hasta kabul\u00fc<\/strong>: VYVGART SC tedavisinde 2.500'den fazla hasta<\/li> <li><strong>\u00dcr\u00fcn hatt\u0131 ba\u015far\u0131s\u0131<\/strong>: Birden fazla faz 3 \u00e7al\u0131\u015fmas\u0131 olumlu veriler sunuyor<\/li> <\/ol> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve \u015firket ivmesine dayanarak:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 650-700 $ (g\u00fc\u00e7l\u00fc 4. \u00e7eyrek sat\u0131\u015flar\u0131 + \u00fcr\u00fcn hatt\u0131 g\u00fcncellemeleri) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li> <li><strong>2026 Hedefi<\/strong>: 750-800 $ (pazar geni\u015flemesi + yeni endikasyonlar)<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 950-1.100 $ (otoimm\u00fcn alanda k\u00fcresel hakimiyet)<\/li> <li><strong>2030 Vizyonu<\/strong>: 1.300-1.500 $ (terap\u00f6tik kategori liderli\u011fi)<\/li> <\/ul> <p><strong>Sonu\u00e7<\/strong>: Bu sadece bir ticaret de\u011fil\u2014uzun vadeli bir bile\u015fik b\u00fcy\u00fcme hikayesi. Temel hikaye s\u00fcrekli de\u011fer art\u0131\u015f\u0131n\u0131 destekliyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>FDA d\u00fczenleyici belirsizli\u011fi<\/strong>: Vyvgart Hytrulo ile ilgili yak\u0131n zamanda yay\u0131nlanan g\u00fcvenlik uyar\u0131s\u0131 ge\u00e7ici volatiliteye neden oldu (<a href=\"https:\/\/www.ainvest.com\/news\/argenx-fda-june-2025-safety-alert-navigating-regulatory-risk-market-valuation-uncertainty-2507\/\">AInvest Raporu<\/a>)<\/li> <li><strong>Tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: VYVGART serisine a\u015f\u0131r\u0131 ba\u011f\u0131ml\u0131l\u0131k<\/li> <li><strong>Biyoteknoloji volatilitesi<\/strong>: Sekt\u00f6r genellikle genel piyasadan daha b\u00fcy\u00fck dalgalanmalar ya\u015far<\/li> <li><strong>Rekabetin artmas\u0131<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketlerinin otoimm\u00fcn alana girmesi<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Kazan\u00e7 s\u00fcrprizleri<\/strong>: Beklentileri geni\u015f farklarla a\u015fma<\/li> <li><strong>\u00dcr\u00fcn hatt\u0131 d\u00f6n\u00fcm noktalar\u0131<\/strong>: 2025 ikinci yar\u0131s\u0131nda \u00fc\u00e7 ek \u00fcst d\u00fczey veri a\u00e7\u0131klamas\u0131 bekleniyor<\/li> <li><strong>Pazar geni\u015flemesi<\/strong>: CIDP lansman\u0131 beklentileri a\u015farak 2.500'den fazla hasta<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Otoimm\u00fcn tedavi pazar\u0131 y\u0131ll\u0131k %14 b\u00fcy\u00fcyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Rahat oldu\u011funuz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n (1-2 hisse bile olabilir)<\/li> <li><strong>Ortalama maliyet y\u00f6ntemi<\/strong>: T\u00fcm\u00fcn\u00fc bir kerede almak yerine par\u00e7a par\u00e7a almay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li> <li><strong>30 Ekim i\u00e7in uyar\u0131 kurun<\/strong>: Kazan\u00e7 g\u00fcn\u00fc giri\u015f f\u0131rsat\u0131 sunabilir<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu 3-5 y\u0131ll\u0131k bir hikaye, haftal\u0131k bir ticaret de\u011fil<\/li> <\/ol> <p>Esprili bir bak\u0131\u015f: \"ARGX ticareti yapmak, zeki bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014bazen kaprisli ama uzun vadeli kazan\u00e7lar ara s\u0131ra ya\u015fanan dramaya kesinlikle de\u011fer!\"<\/p> <h2>\u2705 argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>Uluslararas\u0131 hisseler ve Euronext Amsterdam eri\u015fimi sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Uzun vadeli yat\u0131r\u0131m yapabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"ARGX\" aramas\u0131 yap\u0131n<\/td><td>Sadece \u015firket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>\u0130\u015flem yapmadan \u00f6nce \u00fccretleri ve d\u00f6viz kurlar\u0131n\u0131 \u00e7ift kontrol edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option ARGX'i Neden Eri\u015filebilir K\u0131lar?<\/h2> <p>ARGX gibi uluslararas\u0131 hisselerde pozisyon olu\u015fturmak isteyen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum depozito<\/strong>: Sadece 5 $ ile ba\u015flay\u0131n\u2014stratejileri test etmek i\u00e7in ideal<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama<\/strong>: Tek belge y\u00fcklemesi ile KYC tamamlan\u0131r<\/li> <li><strong>K\u00fcresel eri\u015fim<\/strong>: Birden fazla uluslararas\u0131 borsadan hisse senedi ticareti yap\u0131n<\/li> <li><strong>Par\u00e7al\u0131 hisse<\/strong>: Tam hisse almadan pozisyonunuzu kademeli olarak olu\u015fturun<\/li> <\/ul> <h2>\ud83c\udf0d 2025'te argenx: \u0130mm\u00fcnolojinin Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2> <p>argenx, klinik a\u015fama biyoteknolojiden ticari bir g\u00fc\u00e7 merkezine d\u00f6n\u00fc\u015ft\u00fc ve 2025 2. \u00e7eyrekte neredeyse <strong>1 milyar $ \u00e7eyreklik sat\u0131\u015f<\/strong> ger\u00e7ekle\u015ftirdi. \u015eirket, amiral gemisi VYVGART platformu ile neonatal Fc resept\u00f6r engelleyici alan\u0131nda lider konumda olup, genel miyastenia gravis ve kronik inflamatuar demiyelinizan polin\u00f6ropati gibi hastal\u0131klar\u0131 tedavi ediyor.<\/p> <p><strong>Mevcut pazar konumu<\/strong>: 10 devam eden kay\u0131t \u00e7al\u0131\u015fmas\u0131 ve ABD, Avrupa ile Japonya'da geni\u015fleyen k\u00fcresel varl\u0131\u011f\u0131 ile otoimm\u00fcn antikor terapilerinde lider.<\/p> <p><strong>2025 ilgin\u00e7 bilgi<\/strong>: argenx, tenis efsanesi Monica Seles ile otoimm\u00fcn hastal\u0131klar fark\u0131ndal\u0131\u011f\u0131n\u0131 art\u0131rmak i\u00e7in ortakl\u0131k kurdu\u2014spor \u00fcnl\u00fcs\u00fc ile hasta savunuculu\u011funu benzersiz bir pazarlama kampanyas\u0131nda birle\u015ftirerek k\u00fcresel \u00e7apta yank\u0131 uyand\u0131rd\u0131.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 argenx Hisse Performans\u0131: G\u00fcncel Durum ve Kritik Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla argenx SE (ARGX) hisseleri <strong>580,00 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Ancak yat\u0131r\u0131m zamanlaman\u0131z i\u00e7in as\u0131l \u00f6nemli olan \u015fudur&#8230;<\/p>\n<p><strong>Takviminize Not Edin: 30 Ekim 2025<\/strong><\/p>\n<p>Bu tarih ARGX yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in her \u015feyi dramatik \u015fekilde de\u011fi\u015ftirebilir. \u015eirketin 2025 3. \u00c7eyrek kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 g\u00fcn ve tarihsel olarak bu t\u00fcr olaylar hisse fiyat\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde etkiliyor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 ARGX Hisselerini Nas\u0131l Etkiler?<\/h3>\n<p>Son \u00e7eyreklerden \u00f6rnek desenleri g\u00f6stereyim:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>31 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>550 $ (tahmin)<\/td>\n<td><strong>%5,5 Art\u0131\u015f<\/strong> (beklentileri a\u015ft\u0131)<\/td>\n<\/tr>\n<tr>\n<td>8 May\u0131s 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>520 $ (tahmin)<\/td>\n<td><strong>%4,2 Art\u0131\u015f<\/strong> (sa\u011flam performans)<\/td>\n<\/tr>\n<tr>\n<td>\u015eubat 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>490 $ (tahmin)<\/td>\n<td><strong>%8,0 Art\u0131\u015f<\/strong> (ola\u011fan\u00fcst\u00fc b\u00fcy\u00fcme)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend Bilgisi<\/strong>: argenx kazan\u00e7 tahminlerini tutarl\u0131 \u015fekilde a\u015ft\u0131\u011f\u0131nda\u2014ki bunu s\u00fcrekli yap\u0131yor\u2014hisse genellikle birka\u00e7 g\u00fcn i\u00e7inde %4-8 aras\u0131nda s\u0131\u00e7rama yap\u0131yor. 31 Temmuz raporu \u00f6zellikle etkileyiciydi; hisse ba\u015f\u0131na 3,74 $ kazan\u00e7, 2,84 $ olan konsens\u00fcs tahminini ezdi ge\u00e7ti.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Ola\u011fan\u00fcst\u00fc ARGX Hikayesi<\/h2>\n<p>Mart&#8217;tan A\u011fustos 2025&#8217;e kadar ARGX hisseleri etkileyici bir <strong>%17,3<\/strong> de\u011fer art\u0131\u015f\u0131 sa\u011flad\u0131:<\/p>\n<ul>\n<li><strong>Mart 2025<\/strong>: 495 $ (k\u0131\u015f konsolidasyon sonras\u0131)<\/li>\n<li><strong>May\u0131s 2025<\/strong>: 535 $ (1. \u00e7eyrek kazan\u00e7 art\u0131\u015f\u0131 + \u00fcr\u00fcn hatt\u0131 ilerlemesi)<\/li>\n<li><strong>Temmuz 2025<\/strong>: 575 $ (2. \u00e7eyrek m\u00fcthi\u015f sonu\u00e7lar + FDA d\u00f6n\u00fcm noktalar\u0131)<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 580 $ (hafif geri \u00e7ekilme ile mevcut seviyeler)<\/li>\n<\/ul>\n<p><strong>S\u00fcrekli b\u00fcy\u00fcmenin nedeni nedir?<\/strong> \u00dc\u00e7 g\u00fc\u00e7l\u00fc fakt\u00f6r:<\/p>\n<ol>\n<li><strong>Gelir patlamas\u0131<\/strong>: 949 milyon $ 2. \u00e7eyrek k\u00fcresel sat\u0131\u015flar (<a href=\"https:\/\/argenx.com\/news\/2024\/argenx-reports-half-year-2025-financial-results-and-provides-sec\">2025 \u0130lk Yar\u0131 Raporu<\/a>)<\/li>\n<li><strong>Hasta kabul\u00fc<\/strong>: VYVGART SC tedavisinde 2.500&#8217;den fazla hasta<\/li>\n<li><strong>\u00dcr\u00fcn hatt\u0131 ba\u015far\u0131s\u0131<\/strong>: Birden fazla faz 3 \u00e7al\u0131\u015fmas\u0131 olumlu veriler sunuyor<\/li>\n<\/ol>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 B\u00fcy\u00fcme Yolu<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve \u015firket ivmesine dayanarak:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 650-700 $ (g\u00fc\u00e7l\u00fc 4. \u00e7eyrek sat\u0131\u015flar\u0131 + \u00fcr\u00fcn hatt\u0131 g\u00fcncellemeleri) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/li>\n<li><strong>2026 Hedefi<\/strong>: 750-800 $ (pazar geni\u015flemesi + yeni endikasyonlar)<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 950-1.100 $ (otoimm\u00fcn alanda k\u00fcresel hakimiyet)<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 1.300-1.500 $ (terap\u00f6tik kategori liderli\u011fi)<\/li>\n<\/ul>\n<p><strong>Sonu\u00e7<\/strong>: Bu sadece bir ticaret de\u011fil\u2014uzun vadeli bir bile\u015fik b\u00fcy\u00fcme hikayesi. Temel hikaye s\u00fcrekli de\u011fer art\u0131\u015f\u0131n\u0131 destekliyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>FDA d\u00fczenleyici belirsizli\u011fi<\/strong>: Vyvgart Hytrulo ile ilgili yak\u0131n zamanda yay\u0131nlanan g\u00fcvenlik uyar\u0131s\u0131 ge\u00e7ici volatiliteye neden oldu (<a href=\"https:\/\/www.ainvest.com\/news\/argenx-fda-june-2025-safety-alert-navigating-regulatory-risk-market-valuation-uncertainty-2507\/\">AInvest Raporu<\/a>)<\/li>\n<li><strong>Tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131<\/strong>: VYVGART serisine a\u015f\u0131r\u0131 ba\u011f\u0131ml\u0131l\u0131k<\/li>\n<li><strong>Biyoteknoloji volatilitesi<\/strong>: Sekt\u00f6r genellikle genel piyasadan daha b\u00fcy\u00fck dalgalanmalar ya\u015far<\/li>\n<li><strong>Rekabetin artmas\u0131<\/strong>: Daha b\u00fcy\u00fck ila\u00e7 \u015firketlerinin otoimm\u00fcn alana girmesi<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Kazan\u00e7 s\u00fcrprizleri<\/strong>: Beklentileri geni\u015f farklarla a\u015fma<\/li>\n<li><strong>\u00dcr\u00fcn hatt\u0131 d\u00f6n\u00fcm noktalar\u0131<\/strong>: 2025 ikinci yar\u0131s\u0131nda \u00fc\u00e7 ek \u00fcst d\u00fczey veri a\u00e7\u0131klamas\u0131 bekleniyor<\/li>\n<li><strong>Pazar geni\u015flemesi<\/strong>: CIDP lansman\u0131 beklentileri a\u015farak 2.500&#8217;den fazla hasta<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: Otoimm\u00fcn tedavi pazar\u0131 y\u0131ll\u0131k %14 b\u00fcy\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Rahat oldu\u011funuz bir pozisyon b\u00fcy\u00fckl\u00fc\u011f\u00fc ile ba\u015flay\u0131n (1-2 hisse bile olabilir)<\/li>\n<li><strong>Ortalama maliyet y\u00f6ntemi<\/strong>: T\u00fcm\u00fcn\u00fc bir kerede almak yerine par\u00e7a par\u00e7a almay\u0131 d\u00fc\u015f\u00fcn\u00fcn<\/li>\n<li><strong>30 Ekim i\u00e7in uyar\u0131 kurun<\/strong>: Kazan\u00e7 g\u00fcn\u00fc giri\u015f f\u0131rsat\u0131 sunabilir<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu 3-5 y\u0131ll\u0131k bir hikaye, haftal\u0131k bir ticaret de\u011fil<\/li>\n<\/ol>\n<p>Esprili bir bak\u0131\u015f: &#8220;ARGX ticareti yapmak, zeki bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014bazen kaprisli ama uzun vadeli kazan\u00e7lar ara s\u0131ra ya\u015fanan dramaya kesinlikle de\u011fer!&#8221;<\/p>\n<h2>\u2705 argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>Uluslararas\u0131 hisseler ve Euronext Amsterdam eri\u015fimi sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Uzun vadeli yat\u0131r\u0131m yapabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;ARGX&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>Sadece \u015firket ad\u0131 de\u011fil, borsa sembol\u00fcn\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>\u0130\u015flem yapmadan \u00f6nce \u00fccretleri ve d\u00f6viz kurlar\u0131n\u0131 \u00e7ift kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option ARGX&#8217;i Neden Eri\u015filebilir K\u0131lar?<\/h2>\n<p>ARGX gibi uluslararas\u0131 hisselerde pozisyon olu\u015fturmak isteyen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito<\/strong>: Sadece 5 $ ile ba\u015flay\u0131n\u2014stratejileri test etmek i\u00e7in ideal<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama<\/strong>: Tek belge y\u00fcklemesi ile KYC tamamlan\u0131r<\/li>\n<li><strong>K\u00fcresel eri\u015fim<\/strong>: Birden fazla uluslararas\u0131 borsadan hisse senedi ticareti yap\u0131n<\/li>\n<li><strong>Par\u00e7al\u0131 hisse<\/strong>: Tam hisse almadan pozisyonunuzu kademeli olarak olu\u015fturun<\/li>\n<\/ul>\n<h2>\ud83c\udf0d 2025&#8217;te argenx: \u0130mm\u00fcnolojinin Y\u00fckselen Y\u0131ld\u0131z\u0131<\/h2>\n<p>argenx, klinik a\u015fama biyoteknolojiden ticari bir g\u00fc\u00e7 merkezine d\u00f6n\u00fc\u015ft\u00fc ve 2025 2. \u00e7eyrekte neredeyse <strong>1 milyar $ \u00e7eyreklik sat\u0131\u015f<\/strong> ger\u00e7ekle\u015ftirdi. \u015eirket, amiral gemisi VYVGART platformu ile neonatal Fc resept\u00f6r engelleyici alan\u0131nda lider konumda olup, genel miyastenia gravis ve kronik inflamatuar demiyelinizan polin\u00f6ropati gibi hastal\u0131klar\u0131 tedavi ediyor.<\/p>\n<p><strong>Mevcut pazar konumu<\/strong>: 10 devam eden kay\u0131t \u00e7al\u0131\u015fmas\u0131 ve ABD, Avrupa ile Japonya&#8217;da geni\u015fleyen k\u00fcresel varl\u0131\u011f\u0131 ile otoimm\u00fcn antikor terapilerinde lider.<\/p>\n<p><strong>2025 ilgin\u00e7 bilgi<\/strong>: argenx, tenis efsanesi Monica Seles ile otoimm\u00fcn hastal\u0131klar fark\u0131ndal\u0131\u011f\u0131n\u0131 art\u0131rmak i\u00e7in ortakl\u0131k kurdu\u2014spor \u00fcnl\u00fcs\u00fc ile hasta savunuculu\u011funu benzersiz bir pazarlama kampanyas\u0131nda birle\u015ftirerek k\u00fcresel \u00e7apta yank\u0131 uyand\u0131rd\u0131.<\/p>\n"},"faq":[{"question":"argenx SE (ARGX) hisseleri nereden al\u0131nabilir?","answer":"ARGX hisseleri, Euronext Amsterdam borsas\u0131nda i\u015flem g\u00f6rmektedir. Uluslararas\u0131 hisse senedi al\u0131m sat\u0131m\u0131 sunan bir\u00e7ok online arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"argenx hisselerine yat\u0131r\u0131m yapman\u0131n riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda FDA d\u00fczenleyici belirsizlikleri, tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, biyoteknoloji sekt\u00f6r\u00fcndeki volatilite ve artan rekabet yer almaktad\u0131r."},{"question":"ARGX hisselerinin 2025-2030 fiyat tahmini nedir?","answer":"Analist konsens\u00fcs\u00fcne g\u00f6re 2025 sonunda 650-700 $, 2030 y\u0131l\u0131nda ise 1.300-1.500 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayan biri ARGX hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p, dolar maliyet ortalamas\u0131 yaparak ve \u00f6nemli kazan\u00e7 raporu tarihleri i\u00e7in uyar\u0131lar kurarak uzun vadeli d\u00fc\u015f\u00fcnmek en iyi yakla\u015f\u0131md\u0131r."},{"question":"Pocket Option ARGX yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, k\u00fcresel borsalara eri\u015fim ve par\u00e7al\u0131 hisse al\u0131m imkan\u0131 sunmas\u0131 nedeniyle yeni yat\u0131r\u0131mc\u0131lar i\u00e7in avantajl\u0131d\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"argenx SE (ARGX) hisseleri nereden al\u0131nabilir?","answer":"ARGX hisseleri, Euronext Amsterdam borsas\u0131nda i\u015flem g\u00f6rmektedir. Uluslararas\u0131 hisse senedi al\u0131m sat\u0131m\u0131 sunan bir\u00e7ok online arac\u0131 kurum ve ticaret platformu \u00fczerinden sat\u0131n al\u0131nabilir."},{"question":"argenx hisselerine yat\u0131r\u0131m yapman\u0131n riskleri nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda FDA d\u00fczenleyici belirsizlikleri, tek \u00fcr\u00fcn ba\u011f\u0131ml\u0131l\u0131\u011f\u0131, biyoteknoloji sekt\u00f6r\u00fcndeki volatilite ve artan rekabet yer almaktad\u0131r."},{"question":"ARGX hisselerinin 2025-2030 fiyat tahmini nedir?","answer":"Analist konsens\u00fcs\u00fcne g\u00f6re 2025 sonunda 650-700 $, 2030 y\u0131l\u0131nda ise 1.300-1.500 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Yeni ba\u015flayan biri ARGX hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck pozisyonlarla ba\u015flay\u0131p, dolar maliyet ortalamas\u0131 yaparak ve \u00f6nemli kazan\u00e7 raporu tarihleri i\u00e7in uyar\u0131lar kurarak uzun vadeli d\u00fc\u015f\u00fcnmek en iyi yakla\u015f\u0131md\u0131r."},{"question":"Pocket Option ARGX yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, k\u00fcresel borsalara eri\u015fim ve par\u00e7al\u0131 hisse al\u0131m imkan\u0131 sunmas\u0131 nedeniyle yeni yat\u0131r\u0131mc\u0131lar i\u00e7in avantajl\u0131d\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T19:53:39+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T19:53:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/\",\"name\":\"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"datePublished\":\"2025-08-25T19:53:39+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp\",\"width\":2560,\"height\":1429},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/","og_locale":"tr_TR","og_type":"article","og_title":"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T19:53:39+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T19:53:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/","name":"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","datePublished":"2025-08-25T19:53:39+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals14-scaled.webp","width":2560,"height":1429},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-argenx-se\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"argenx SE (ARGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; argenx SE (ARGX) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":350637,"slug":"how-to-buy-argenx-se","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu argenx SE (ARGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu argenx SE (ARGX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-argenx-se\/"},"pt_AA":{"locale":"pt_AA","id":350640,"slug":"how-to-buy-argenx-se","post_title":"Como comprar a\u00e7\u00f5es da argenx SE (ARGX) - Investimento em a\u00e7\u00f5es da argenx SE (ARGX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-argenx-se\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/350634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=350634"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/350634\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334108"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=350634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=350634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=350634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}